T16	Exp 278 308	their T-cell antigen receptors
T17	Exp 251 255	when
T18	Exp 267 273	either
T19	Exp 321 359	The molecular mechanism(s) responsible
T20	Exp 364 379	this phenomenon
T21	Exp 414 416	We
T22	Exp 435 439	that
T23	Exp 525 564	the transcriptional regulatory elements
T24	Exp 440 452	such defects
T25	Exp 597 599	We
T26	Exp 664 668	both
T27	Exp 833 835	We
T28	Exp 848 852	that
T29	Exp 939 952	the 27th week
T30	Exp 876 900	these regulatory factors
T31	Exp 1306 1308	We
T32	Exp 1318 1322	that
T33	Exp 1469 1478	the mRNAs
T34	Exp 1483 1496	these factors
T35	Exp 1567 1579	the capacity
T36	Exp 1592 1605	these factors
T37	Exp 1724 1741	the IL-2 promoter
T38	Exp 1693 1720	these transcription factors
T39	SPAN 113 128	c-fos and c-jun
R5	Coref Anaphora:T18 Antecedent:T39
T40	SPAN 113 128	c-fos and c-jun
R6	Coref Anaphora:T16 Antecedent:T40
T41	SPAN 789 801	c-jun, c-fos
R7	Coref Anaphora:T30 Antecedent:T41
T42	SPAN 1116 1131	c-jun and c-fos
R8	Coref Anaphora:T34 Antecedent:T42
T43	SPAN 1116 1131	c-jun and c-fos
R9	Coref Anaphora:T36 Antecedent:T43
T1	Protein 24 29	c-fos
T2	Protein 31 36	c-jun
T3	Protein 113 118	c-fos
T4	Protein 123 128	c-jun
T5	Protein 789 794	c-jun
T6	Protein 796 801	c-fos
T7	Protein 819 822	p50
T8	Protein 1116 1121	c-jun
T9	Protein 1126 1131	c-fos
T10	Protein 1190 1194	IL-2
T11	Protein 1728 1732	IL-2
